SUMMARY
Choosing the right Market Access activities plays a pivotal role for successful launch of new, pharmaceutical products.
Success hinges on strong, cross-functional teamwork, especially between commercial, medical, regulatory affairs, and market access teams.
During this two day course, you get in-depth knowledge about market access work in pharmaceutical companies including the most important internal and external stakeholders, how you can best contribute to a successful market access effort.
This course builds on insights and learnings from the course Introduction to Market Access and prepares you for participation in the subsequent market access course: Securing Market Uptake
Other course participants say
"Good lecturers who provide coherence in a field that is difficult to manoeuvre."
Henrik Lykkeby Jacobsen, Sr. Key Account Manager, medac.
"Valuable insights and understanding of a complex area with huge significance in our cross-functional daily work. Highly competent educators who managed to explain complex things simply."
Evy Skovhaur, Disease Area Manager, Oncology, Novartis Healthcare A/S
"A very good course where the learnings were made very practical and applicable."
Hans-Jakob Sørensen, Medical Advisor, GSK Denmark
"I gained a lot from both days, not only in terms of market access but also in how it's linked to other functions. The two instructors were skilled, had the answers to everything and treated every question respectfully."
Susanne Capion, Market Access & HC Affairs Manager, Boehringer Ingelheim
"Great interactions with participants as well as great programme and speakers."
Kirsten Brendborg, Key Account Manager GSK, GSK Pharma A/S
Keywords
- Cross-functional collaboration
- Danish Medicines Council
- Pricing and negotiation
- Health economics
Hi!
Do you need help choosing the right course?
We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com
Save information for later
Course leader & lecturers
- Anne KolbyeCourse leaderValue Demonstration Manager
Roche A/S - Sune Tüxen JørgensenCourse leaderBusiness Lead
Roche A/S - Niels Juul BrogaardLecturerSenior Payer Evidence Generation Manager
Novo Nordisk A/S - Christian Graves BeckLecturerNordic HTA Enabler
Roche A/S
Watch the video
Is this course for you?
You either work in Market Access or closely together with the Market Access team in a pharma company on the Danish market.
What will you learn
- You will learn how to organise and execute cross-functional ways of working in the triangle between market access, commercial and medical.
- You follow a company's process towards getting a new pharmaceutical through a Medicines Council process.
- You will be introduced to real success and failure cases and the key learnings from these.
- Through case work you will get the opportunity to plan your own market access strategy, to test your ideas and get feedback from the course leaders.
What your company will get
- An employee, who understands the processes involved in gaining market access and can work with the key stakeholders involved in these processes.
- An employee, who knows how to plan a market access strategy involving cross-functional collaboration.
- An employee, who knows and understands the use of QALY as a cost utility measure, a budget impact plan, and a health economic analysis.
- An employee, who understands how pricing and negotiation with payers take place.
Course calendar
Day 1
- From traditional organisation to cross-functional ways of working
- The process for evaluating medicinal products in the Danish Medicines Counsel
- A drug’s way through the Danish Medicines Council.
Day 2
- Introduction to the day and recap of day 1.
- Pricing in the primary and secondary sector.
- Price negotiations with AMGROS (representing payer in Denmark).
- There is more to market access than the Danish Medicines Counsel.
- Case: preparation of a market access strategy for a primary or secondary sector pharmaceutical product.
Registration
Registration deadline26 Sep 2025
Lersø Parkallé 101
2100 København Ø
Day 1
- From traditional organisation to cross-functional ways of working
- The process for evaluating medicinal products in the Danish Medicines Counsel
- A drug’s way through the Danish Medicines Council.
Day 2
- Introduction to the day and recap of day 1.
- Pricing in the primary and secondary sector.
- Price negotiations with AMGROS (representing payer in Denmark).
- There is more to market access than the Danish Medicines Counsel.
- Case: preparation of a market access strategy for a primary or secondary sector pharmaceutical product.
Registration
Registration deadline25 Sep 2026
Lersø Parkallé 101
2100 København Ø
Course information
Literature
Prior to the course you get access to mandatory and/or optional readings via your personal Atrium log-in.
Prerequisites
If the Market Access field is new to you, we recommend that you have attended the course, Introduction to Market Access , beforehand.
Examination
This course is mandatory curriculum, if you wish to take a Diploma in Market Access
This course is a part of a diploma
Our Diploma in Market Access provides you with in-depth knowledge of the Danish healthcare system and its funding models and stakeholders. Raise your skill level in areas such as public affairs, stakeholder management and health economics by attending the four courses
Read moreCourse leaders
Roche A/S
Roche A/S
Lecturers
Roche A/S
Novo Nordisk A/S
Roche A/S
Roche A/S
You may also be interested in these courses
21 Apr 2026
•
Want to know more or need help?
Contact Client Manager Ida Salicath at +45 39 15 09 46
Send me a message